AVISAN MULTI/CO
Inactivated vaccine against Infectious Bronchitis, Newcastle disease, Egg Drop Syndrome-76 and Infectious Coryza, in injectable emulsion

QUALITATIVE AND QUANTITATIVE COMPOSITION:
Composition per dose (0.5 ml):
Infectious Bronchitis Virus inactivated, strain H52 ≥ 10 6 EID50
Newcastle Disease Virus inactivated, strain La Sota ≥ 10 8 EID50
Egg Drop Syndrome Virus inactivated, strain Adenovirus-127 ≥ 307.2 HAU
Avibacterium paragallinarum, serotype A ≥ 1.25 x 10 9 microorganisms.
Avibacterium paragallinarum, serotype B ≥ 1.25 x 10 9 microorganisms.
 Avibacterium paragallinarum, serotype C ≥ 1.25 x 10 9 microorganisms.

INDICATIONS FOR USE:
Poultry: To prevent Infectious Bronchitis, Newcastle Disease, Egg Drop Syndrome-76 and Infectious Coriza.

TARGET SPECIES:
Poultry.

DOSAGE FOR EACH SPECIES, ROUTES AND METHOD OF ADMINISTRATION:
Poultry: 0.5 ml / bird.
In situations of adequate epidemiological surveillance of the IB, ND, EDS and Infectious Coryza diseases, administer one dose no later than 2-3 weeks before the onset of laying, subcutaneously in the mid-dorsal region of the neck, in the opposite direction to the head or intramuscularly in the breast. In general, the vaccine can be used at any time during breeding or rearing depending on the development of the disease. The suggested vaccination programme when clinical outbreaks of IB, ND, EDS and Infectious Coryza are present is, rst vaccination at 8-12 weeks and revaccination 2 to 3 weeks before the onset of laying. There should be a 6-week interval between both vaccinations. To ensure a good level of protection in birds that are only subjected to a high infection pressure from Avibacterium paragallinarum (Infectious Coryza), birds should be vaccinated between 6 and 8 weeks of age with CORIPRAVAC, and revaccinated with AVISAN MULTI/CO, at the latest, 2 to 3 weeks before the onset of laying. There should be a 6-week interval between both vaccinations.

ADVICE ON CORRECT ADMINISTRATION:
It is advisable to administer the vaccine at a temperature between +15 and +25 ºC. Shake before use and during administration. Use sterile equipment when administering. If inoculation by subcutaneous route is not correct and it is carried out by intradermic route, it may produce a regional oedema of favourable evolution. Do not inject in cervical vertebrae.

WITHDRAWAL PERIOD:
Zero days.

SPECIAL PRECAUTIONS FOR STORAGE:
Keep out of reach and sight of children.
Store and transport refrigerated (+2 to +8 ºC).
Do not freeze. Protect from light.

SPECIAL WARNINGS:
This product contains a mineral oil based compound. It may cause severe pain and in ammation in the case of accidental self-injection. Clean and disinfect the wound immediately, see a doctor and show him this lea et.

SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED VETERINARY MEDICINAL PRODUCT OR WASTE MATERIALS DERIVED FROM THE USE OF SUCH PRODUCTS.

 
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal should be disposed of in accordance with local requirements.

OTHER INFORMATION:
Pack sizes:
Bottle of 1,000 doses (500 ml). T